Athena Feminine Technologies, Inc – Trademark Portfolio
Entity Type: 03
Athena Feminine Technologies, Inc holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ATHENA FREEDOM, ATHENA FEMININE TECHNOLOGIES, and ATHENA PELVIC MUSCLE TRAINER. The owner is based in Orinda, CA.
179 Moraga Way
Orinda, CA 94563
Showing of trademarks Trademarks
Trademark Classifications
Athena Feminine Technologies, Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Athena Feminine Technologies, Inc have?
Athena Feminine Technologies, Inc has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Athena Feminine Technologies, Inc file in?
Athena Feminine Technologies, Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Athena Feminine Technologies, Inc's most well-known trademarks?
Athena Feminine Technologies, Inc's registered trademark portfolio includes well-known marks such as ATHENA FREEDOM, ATHENA FEMININE TECHNOLOGIES, and ATHENA PELVIC MUSCLE TRAINER. These are among 3 currently registered trademarks in the portfolio.
What is Athena Feminine Technologies, Inc's trademark registration success rate?
Athena Feminine Technologies, Inc has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.